Lincoff PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
A Michael Lincoff MD PowerPoint PPT Presentation
A Michael Lincoff MD - ... on study of the saliva of the medicinal leech. Directly and reversibly binds to thrombin molecule at 2 ... direct thrombin inhibitor, not neutralized by ...
... on study of the saliva of the medicinal leech. Directly and reversibly binds to thrombin molecule at 2 ... direct thrombin inhibitor, not neutralized by ...
| PowerPoint PPT presentation | free to view
CHAMPION PLATFORM PowerPoint PPT Presentation
CHAMPION PLATFORM - Deepak L. Bhatt, MD, MPH, A. Michael Lincoff, MD, C. Michael Gibson, MS, MD, Gregg W. Stone, MD, Steven McNulty, MS, Gilles Montalescot, MD, PhD,
Deepak L. Bhatt, MD, MPH, A. Michael Lincoff, MD, C. Michael Gibson, MS, MD, Gregg W. Stone, MD, Steven McNulty, MS, Gilles Montalescot, MD, PhD,
| PowerPoint PPT presentation | free to download
Clinical Trials of GP IIbIIIa Inhibition PowerPoint PPT Presentation
Clinical Trials of GP IIbIIIa Inhibition - ESPRIT: Study design. Eptifibatide. 180- g/kg ... ESPRIT Investigators. ... ESPRIT: Primary outcome over time. VBWG. Lincoff AM et al. J Am Coll ...
ESPRIT: Study design. Eptifibatide. 180- g/kg ... ESPRIT Investigators. ... ESPRIT: Primary outcome over time. VBWG. Lincoff AM et al. J Am Coll ...
| PowerPoint PPT presentation | free to view
Diabetes and Cardiovascular Disease: The Role of the Glycoprotein llb/llla Inhibitors PowerPoint PPT Presentation
Diabetes and Cardiovascular Disease: The Role of the Glycoprotein llb/llla Inhibitors - Diabetes and Cardiovascular Disease: The Role of the Glycoprotein llb/llla Inhibitors A. Michael Lincoff, MD, FACC, Editor Associate Professor of Medicine
Diabetes and Cardiovascular Disease: The Role of the Glycoprotein llb/llla Inhibitors A. Michael Lincoff, MD, FACC, Editor Associate Professor of Medicine
| PowerPoint PPT presentation | free to download
Pioglitazone and Vascular Risk in Type 2 Diabetes: A MetaAnalysis PowerPoint PPT Presentation
Pioglitazone and Vascular Risk in Type 2 Diabetes: A MetaAnalysis - To systematically evaluate the effect of the ... complications in diabetic patients using complete patient ... Clinical trial data maintained by ...
To systematically evaluate the effect of the ... complications in diabetic patients using complete patient ... Clinical trial data maintained by ...
| PowerPoint PPT presentation | free to view
Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus PowerPoint PPT Presentation
Effect of Aleglitazar on Cardiovascular Outcomes After Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus - Effects of / PPAR Activation. Nuclear receptors that function as transcription factors regulating the expression of genes Insulin . sensitivity
Effects of / PPAR Activation. Nuclear receptors that function as transcription factors regulating the expression of genes Insulin . sensitivity
| PowerPoint PPT presentation | free to download
Clinical Trials of GP IIb/IIIa Inhibition PowerPoint PPT Presentation
Clinical Trials of GP IIb/IIIa Inhibition - Clinical Trials of GP IIb/IIIa Inhibition Major Trials of GP IIb/IIIa Inhibitors in ACS GP IIb/IIIa Inhibitors in PCI GP IIb/IIIa Inhibition in Patients With Diabetes
Clinical Trials of GP IIb/IIIa Inhibition Major Trials of GP IIb/IIIa Inhibitors in ACS GP IIb/IIIa Inhibitors in PCI GP IIb/IIIa Inhibition in Patients With Diabetes
| PowerPoint PPT presentation | free to view
The Trans Radial Intervention and Patient Subsets (I) PowerPoint PPT Presentation
The Trans Radial Intervention and Patient Subsets (I) - Angina pectoris class .008 -1.1 -1.9. Rose pain score .17. 5.3. 7.2. Duke activity score index ... or older with chronic angina of Canadian Cardiac Society ...
Angina pectoris class .008 -1.1 -1.9. Rose pain score .17. 5.3. 7.2. Duke activity score index ... or older with chronic angina of Canadian Cardiac Society ...
| PowerPoint PPT presentation | free to view
Effect of REG1 Anticoagulation System versus Bivalirudin on Cardiovascular Outcomes Following PCI: PowerPoint PPT Presentation
Effect of REG1 Anticoagulation System versus Bivalirudin on Cardiovascular Outcomes Following PCI: - Effect of REG1 Anticoagulation System versus Bivalirudin on Cardiovascular Outcomes Following PCI: The REGULATE-PCI Randomized Clinical Trial Roxana Mehran, John ...
Effect of REG1 Anticoagulation System versus Bivalirudin on Cardiovascular Outcomes Following PCI: The REGULATE-PCI Randomized Clinical Trial Roxana Mehran, John ...
| PowerPoint PPT presentation | free to view
Jointly Sponsored by the University of Massachusetts Medical School Office of Continuing Education and CMEducation Resources, LLC. PowerPoint PPT Presentation
Jointly Sponsored by the University of Massachusetts Medical School Office of Continuing Education and CMEducation Resources, LLC. - These data form the GRACE registry show that there is an association between bleeding and morality ... Time Admission Cath Discharge No Cath Cath PCI Surgery ...
These data form the GRACE registry show that there is an association between bleeding and morality ... Time Admission Cath Discharge No Cath Cath PCI Surgery ...
| PowerPoint PPT presentation | free to download
Journal Club PowerPoint PPT Presentation
Journal Club - Journal Club Adam G Tabak, Markus Jokela, Tasnime N Akbaraly, Eric J Brunner, Mika Kivimaki, Daniel R Witte Trajectories of glycaemia, insulin sensitivity, and ...
Journal Club Adam G Tabak, Markus Jokela, Tasnime N Akbaraly, Eric J Brunner, Mika Kivimaki, Daniel R Witte Trajectories of glycaemia, insulin sensitivity, and ...
| PowerPoint PPT presentation | free to download
Jointly Sponsored by the University of Massachusetts Medical School Office of Continuing Education and CMEducation Resources, LLC. PowerPoint PPT Presentation
Jointly Sponsored by the University of Massachusetts Medical School Office of Continuing Education and CMEducation Resources, LLC. - Accreditation Information Program Requirements Accreditation Information Accreditation Information ACS Forum Leadership Panel ACS Forum Leadership Panel ACS Forum ...
Accreditation Information Program Requirements Accreditation Information Accreditation Information ACS Forum Leadership Panel ACS Forum Leadership Panel ACS Forum ...
| PowerPoint PPT presentation | free to download
Trend in crescita in cardiologia interventistica e non PowerPoint PPT Presentation
Trend in crescita in cardiologia interventistica e non - ... 15 Diapositiva 16 Diapositiva 17 Diapositiva 18 Diapositiva 19 Point Prevalence of End Stage Renal Disease Cardiorenal Risk Major Causes of Acute Renal ...
... 15 Diapositiva 16 Diapositiva 17 Diapositiva 18 Diapositiva 19 Point Prevalence of End Stage Renal Disease Cardiorenal Risk Major Causes of Acute Renal ...
| PowerPoint PPT presentation | free to download
Starbucks Coffee PowerPoint PPT Presentation
Starbucks Coffee - Silver Springs, Maryland Starbucks 'Nurse-in': Mothers, ... Hired by Starbucks in 1982. Trip to Milan in 1983. Left the ... Starbucks Spokeswoman ...
Silver Springs, Maryland Starbucks 'Nurse-in': Mothers, ... Hired by Starbucks in 1982. Trip to Milan in 1983. Left the ... Starbucks Spokeswoman ...
| PowerPoint PPT presentation | free to view
Starbucks Coffee PowerPoint PPT Presentation
Starbucks Coffee - ... of Starbucks Founded in 1971. Coffee, tea, and spice store. Named in honor of the first mate in Herman Melville s Moby Dick.
... of Starbucks Founded in 1971. Coffee, tea, and spice store. Named in honor of the first mate in Herman Melville s Moby Dick.
| PowerPoint PPT presentation | free to view
Translating Advances in NSTEMI and STEMI into Real World Institutional Practice PowerPoint PPT Presentation
Translating Advances in NSTEMI and STEMI into Real World Institutional Practice - The Science and Medicine of ACS Translating Advances in NSTEMI and STEMI into Real World Institutional Practice Harold L. Dauerman, MD Director, Cardiovascular ...
The Science and Medicine of ACS Translating Advances in NSTEMI and STEMI into Real World Institutional Practice Harold L. Dauerman, MD Director, Cardiovascular ...
| PowerPoint PPT presentation | free to view
UA/NSTEMI Guidelines Audio-Webcast: A Presentation PowerPoint PPT Presentation
UA/NSTEMI Guidelines Audio-Webcast: A Presentation - Chase Medical. Centocor. Celsion Corp. Caro Research. CardioKinetix, Inc. ... KAI Pharmaceuticals. Jomed, Inc. Johnson & Johnson. IOMED. ISIS Pharmaceuticals ...
Chase Medical. Centocor. Celsion Corp. Caro Research. CardioKinetix, Inc. ... KAI Pharmaceuticals. Jomed, Inc. Johnson & Johnson. IOMED. ISIS Pharmaceuticals ...
| PowerPoint PPT presentation | free to download
Jiro Aoki, MD, Gregg W' Stone, MD, Roxana Mehran, MD, Jeffery Moses, MD, Michel E' Bertrand, MD, A' PowerPoint PPT Presentation
Jiro Aoki, MD, Gregg W' Stone, MD, Roxana Mehran, MD, Jeffery Moses, MD, Michel E' Bertrand, MD, A' - Cardiovascular Research Foundation. New York City ... with Acute Coronary Syndromes Treated with Bare Metal and Drug-Eluting Stents: ...
Cardiovascular Research Foundation. New York City ... with Acute Coronary Syndromes Treated with Bare Metal and Drug-Eluting Stents: ...
| PowerPoint PPT presentation | free to view
Why Bleeding Matters in ACS PowerPoint PPT Presentation
Why Bleeding Matters in ACS - Getting in the (Up)Stream of Things Why Bleeding Matters in ACS Importance of Multi-specialty ED and IC Therapeutic (EDICT) Alignment of Upstream Care for ACS
Getting in the (Up)Stream of Things Why Bleeding Matters in ACS Importance of Multi-specialty ED and IC Therapeutic (EDICT) Alignment of Upstream Care for ACS
| PowerPoint PPT presentation | free to view
CHAMPION PLATFORM PowerPoint PPT Presentation
CHAMPION PLATFORM - Gregg W. Stone, MD, Steven McNulty, MS, Gilles Montalescot, MD, PhD, ... Maharaj Nakorn Chiang Mai Hospital. 66. CHAMPION PLATFORM Top 10 Enrollers ...
Gregg W. Stone, MD, Steven McNulty, MS, Gilles Montalescot, MD, PhD, ... Maharaj Nakorn Chiang Mai Hospital. 66. CHAMPION PLATFORM Top 10 Enrollers ...
| PowerPoint PPT presentation | free to view
Unsettled Issues in Adjunct Pharmacology in Acute Coronary Syndrome and PCI PowerPoint PPT Presentation
Unsettled Issues in Adjunct Pharmacology in Acute Coronary Syndrome and PCI - Unsettled Issues in Adjunct Pharmacology in. Acute Coronary Syndrome and PCI. Franz-Josef Neumann ... Low molecular weight heparin verus unfractionated heparin ...
Unsettled Issues in Adjunct Pharmacology in. Acute Coronary Syndrome and PCI. Franz-Josef Neumann ... Low molecular weight heparin verus unfractionated heparin ...
| PowerPoint PPT presentation | free to view
Final Project- PowerPoint PPT Presentation
Final Project- - To know whether we can eat the mushroom, to survive in the wild ... Iba,W., Wogulis,J., & Langley,P. (1988). ICML, 73-79. 2. No other mushrooms data ...
To know whether we can eat the mushroom, to survive in the wild ... Iba,W., Wogulis,J., & Langley,P. (1988). ICML, 73-79. 2. No other mushrooms data ...
| PowerPoint PPT presentation | free to download
Antiplatelet Interventions in Acute Coronary Syndromes PowerPoint PPT Presentation
Antiplatelet Interventions in Acute Coronary Syndromes - Thrombus Susceptibility and the Vulnerable Plaque: ... OPUS-TIMI 16. Sabatine MS et al. Circulation. 2002;105:1760-3. TACTICS-TIMI 18. 1. 1.8 ...
Thrombus Susceptibility and the Vulnerable Plaque: ... OPUS-TIMI 16. Sabatine MS et al. Circulation. 2002;105:1760-3. TACTICS-TIMI 18. 1. 1.8 ...
| PowerPoint PPT presentation | free to view
of atherosclerosis in patients with abdominal obesity an PowerPoint PPT Presentation
of atherosclerosis in patients with abdominal obesity an - of atherosclerosis in patients with abdominal obesity and coronary artery disease ... Abdominal obesity is associated with specific metabolic abnormalities that ...
of atherosclerosis in patients with abdominal obesity and coronary artery disease ... Abdominal obesity is associated with specific metabolic abnormalities that ...
| PowerPoint PPT presentation | free to view
Changing anticoagulants in midstream - what are the benefits and risks? PowerPoint PPT Presentation
Changing anticoagulants in midstream - what are the benefits and risks? - Title: Changing anticoagulants in midstream - what are the benefits and risks? Author: Barbara Semb Last modified by: Milo Falcon Created Date: 3/2/2006 3:19:40 PM
Title: Changing anticoagulants in midstream - what are the benefits and risks? Author: Barbara Semb Last modified by: Milo Falcon Created Date: 3/2/2006 3:19:40 PM
| PowerPoint PPT presentation | free to view
Sergio Berti PowerPoint PPT Presentation
Sergio Berti - ... O2 delivery TAMI 9 Magnesium Membrane stabilisation ISIS4,MAGIC RheothRX O2 delivery CORE Trimetazidine H+, free radicals, neutr. EMIP-FR hSOD Prevent ...
... O2 delivery TAMI 9 Magnesium Membrane stabilisation ISIS4,MAGIC RheothRX O2 delivery CORE Trimetazidine H+, free radicals, neutr. EMIP-FR hSOD Prevent ...
| PowerPoint PPT presentation | free to download
Which Anticoagulant and For How Long PowerPoint PPT Presentation
Which Anticoagulant and For How Long - World Rank Order of Disease Burden (DALY) Lower resp infection ... hypercholesterolemia sheer stress. infection? high homocysteine? ENDOTHELIAL DYSFUNCTION ...
World Rank Order of Disease Burden (DALY) Lower resp infection ... hypercholesterolemia sheer stress. infection? high homocysteine? ENDOTHELIAL DYSFUNCTION ...
| PowerPoint PPT presentation | free to view
STRADIVARIUS Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesi PowerPoint PPT Presentation
STRADIVARIUS Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesi - PAV: primary endpoint. TAV: secondary endpoint -2.2. 0.88. 0.51. 0.25. P 0. ... for rimonabant on the primary endpoint, PAV (P = 0.22), but a favorable effect ...
PAV: primary endpoint. TAV: secondary endpoint -2.2. 0.88. 0.51. 0.25. P 0. ... for rimonabant on the primary endpoint, PAV (P = 0.22), but a favorable effect ...
| PowerPoint PPT presentation | free to view
Overcoming Challenges in Treating Diabetic Patients PowerPoint PPT Presentation
Overcoming Challenges in Treating Diabetic Patients - Director of Research and Chief Executive Officer. Ohio Heart ... VELVET/6mo. 23.4. 0.97. VENUS/6mo. 21.0. 0.80. RAVEL-Ctrl/6mo. 28.2. 1.00. SIRIUS-Ctrl/8mo ...
Director of Research and Chief Executive Officer. Ohio Heart ... VELVET/6mo. 23.4. 0.97. VENUS/6mo. 21.0. 0.80. RAVEL-Ctrl/6mo. 28.2. 1.00. SIRIUS-Ctrl/8mo ...
| PowerPoint PPT presentation | free to view
Correlates of Bleeding After a 600 mg Loading Dose of Clopidogrel, With and Without Abciximab A Pool PowerPoint PPT Presentation
Correlates of Bleeding After a 600 mg Loading Dose of Clopidogrel, With and Without Abciximab A Pool - Bristol-Myers Squibb, Lilly, Cordis, Glaxo SmithKline, Medtronik, Novartis and ... symposia: BMS, Sanofi-Aventis, Lilly/Daiichi Sankyo, Sheering Plough (Modest) ...
Bristol-Myers Squibb, Lilly, Cordis, Glaxo SmithKline, Medtronik, Novartis and ... symposia: BMS, Sanofi-Aventis, Lilly/Daiichi Sankyo, Sheering Plough (Modest) ...
| PowerPoint PPT presentation | free to view
Acute Coronary Syndromes Chapter 28 PowerPoint PPT Presentation
Acute Coronary Syndromes Chapter 28 - ST-elevation myocardial infarction: A report of the ACC/AHA Task Force on ... However, only a small fraction of these abnormalities cause symptomatic ischemia. ...
ST-elevation myocardial infarction: A report of the ACC/AHA Task Force on ... However, only a small fraction of these abnormalities cause symptomatic ischemia. ...
| PowerPoint PPT presentation | free to view
CHARISMA slide set PowerPoint PPT Presentation
CHARISMA slide set - ... M.D., Keith A. A. Fox M.B.Ch.B., Werner Hacke M.D., Peter B. Berger M.D., Henry ... Bhatt DL, Fox KA, Hacke W, et al. NEJM 2006. ...
... M.D., Keith A. A. Fox M.B.Ch.B., Werner Hacke M.D., Peter B. Berger M.D., Henry ... Bhatt DL, Fox KA, Hacke W, et al. NEJM 2006. ...
| PowerPoint PPT presentation | free to view
... Bhatt MD, Keith A A Fox MBChB, Werner Hacke MD, Peter PowerPoint PPT Presentation
... Bhatt MD, Keith A A Fox MBChB, Werner Hacke MD, Peter - ... Bhatt MD, Keith A A Fox MBChB, Werner Hacke MD, Peter B Berger MD, Henry R Black ... Bhatt DL, Fox K, Hacke W, et al. Am Heart J 2005; 150: 401. Trial committees ...
... Bhatt MD, Keith A A Fox MBChB, Werner Hacke MD, Peter B Berger MD, Henry R Black ... Bhatt DL, Fox K, Hacke W, et al. Am Heart J 2005; 150: 401. Trial committees ...
| PowerPoint PPT presentation | free to view
NAPLES Novel Approaches for Preventing or Limiting Event Study Randomised Comparison of Bivalirudin PowerPoint PPT Presentation
NAPLES Novel Approaches for Preventing or Limiting Event Study Randomised Comparison of Bivalirudin - Randomised Comparison of Bivalirudin Monotherapy versus Unfractionated Heparin ... bleeding diathesis, trauma or gastrointestinal or genitourinary tract bleeding ...
Randomised Comparison of Bivalirudin Monotherapy versus Unfractionated Heparin ... bleeding diathesis, trauma or gastrointestinal or genitourinary tract bleeding ...
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2024 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
lincoff — Search results on PowerShow.com